{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:36:30Z","timestamp":1774492590285,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05718-x","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:02:33Z","timestamp":1726502553000},"page":"2621-2635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Onset of leukocytoclastic vasculitis following covid-19 vaccination: case based comprehensive review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-2572","authenticated-orcid":false,"given":"Rada","family":"Miskovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1508-178X","authenticated-orcid":false,"given":"Sara","family":"Radovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-4731","authenticated-orcid":false,"given":"Snezana","family":"Arandjelovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-0874","authenticated-orcid":false,"given":"Aleksandra","family":"Plavsic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5615-5975","authenticated-orcid":false,"given":"Vesna","family":"Reljic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6088-094X","authenticated-orcid":false,"given":"Jelena","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-2779","authenticated-orcid":false,"given":"Voin","family":"Brkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-7344","authenticated-orcid":false,"given":"Maja","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"5718_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/diagnostics13030484","volume":"13","author":"M Stojanovic","year":"2023","unstructured":"Stojanovic M, Barac A, Petkovic A, Vojvodic N, Odalovic S (2023) Large-vessel giant cell arteritis following COVID-19\u2014what can HLA typing reveal? Diagnostics 13:484. https:\/\/doi.org\/10.3390\/diagnostics13030484","journal-title":"Diagnostics"},{"key":"5718_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00296-022-05153-w","volume":"42","author":"C Valero","year":"2022","unstructured":"Valero C, Baldivieso-Ach\u00e1 JP, Uriarte M et al (2022) Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature. Rheumatol Int 42:1643\u20131652. https:\/\/doi.org\/10.1007\/s00296-022-05153-w","journal-title":"Rheumatol Int"},{"key":"5718_CR3","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00296-022-05203-3","volume":"42","author":"I Sagy","year":"2022","unstructured":"Sagy I, Zeller L, Raviv Y, Porges T, Bieber A, Abu-Shakra M (2022) New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review. Rheumatol Int. 42:2261\u20132266. https:\/\/doi.org\/10.1007\/s00296-022-05203-3","journal-title":"Rheumatol Int."},{"key":"5718_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00296-023-05283-9","volume":"43","author":"K Kouranloo","year":"2023","unstructured":"Kouranloo K, Dey M, Elwell H, Nune A (2023) A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatol Int 43:1221\u20131243. https:\/\/doi.org\/10.1007\/s00296-023-05283-9","journal-title":"Rheumatol Int"},{"key":"5718_CR5","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00296-021-04914-3","volume":"41","author":"T Izci Duran","year":"2021","unstructured":"Izci Duran T, Turkmen E, Dilek M, Sayarlioglu H, Arik N (2021) ANCA-associated vasculitis after COVID-19. Rheumatol Int 41:1523\u20131529. https:\/\/doi.org\/10.1007\/s00296-021-04914-3","journal-title":"Rheumatol Int"},{"key":"5718_CR6","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s10067-023-06694-6-6","volume":"42","author":"P Mv","year":"2023","unstructured":"Mv P, Auanassova A, Yessirkepov M, Zimba O, Gasparyan AY, Kitas GD, Ahmed S (2023) New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome. Clin Rheumatol 42:2761\u20132775. https:\/\/doi.org\/10.1007\/s10067-023-06694-6-6","journal-title":"Clin Rheumatol"},{"key":"5718_CR7","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/vaccines11101571","volume":"11","author":"A Nune","year":"2023","unstructured":"Nune A, Durkowski V, Pillay SS, Barman B, Elwell H (2023) New-onset Rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: a systematic review. Vaccines (Basel) 11:1571. https:\/\/doi.org\/10.3390\/vaccines11101571","journal-title":"Vaccines (Basel)"},{"key":"5718_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/cup.14235","volume":"49","author":"Y Azzazi","year":"2022","unstructured":"Azzazi Y, Abdelkader HA, Khedr H, El-Komy MHM (2022) Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature. J Cutan Pathol 49:736\u2013742. https:\/\/doi.org\/10.1111\/cup.14235","journal-title":"J Cutan Pathol"},{"key":"5718_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15651","volume":"35","author":"S Shakoei","year":"2022","unstructured":"Shakoei S, Kalantari Y, Nasimi M, Tootoonchi N, Ansari MS (2022) Cutaneous manifestations following COVID-19 vaccination: a report of 25 cases. Dermatol Ther 35:e15651. https:\/\/doi.org\/10.1111\/dth.15651","journal-title":"Dermatol Ther"},{"key":"5718_CR10","unstructured":"The use of the WHO-UMC system for standardised case causality assessment-1-The use of the WHO-UMC system for standardised case causality assessment Why causality assessment?"},{"key":"5718_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15458","volume":"35","author":"A Abdelmaksoud","year":"2022","unstructured":"Abdelmaksoud A, Wollina U, Temiz SA, Hasan A (2022) SARS-CoV-2 vaccination-induced cutaneous vasculitis: report of two new cases and literature review. Dermatol Ther 35:e15458. https:\/\/doi.org\/10.1111\/dth.15458","journal-title":"Dermatol Ther"},{"key":"5718_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/ijd.15777","volume":"60","author":"E Bostan","year":"2021","unstructured":"Bostan E, Gulseren D, Gokoz O (2021) New-onset leukocytoclastic vasculitis after COVID-19 vaccine. Int J Dermatol 60:1305\u20131306. https:\/\/doi.org\/10.1111\/ijd.15777","journal-title":"Int J Dermatol"},{"key":"5718_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdcr.2021.10.002","volume":"18","author":"R Bencharattanaphakhi","year":"2021","unstructured":"Bencharattanaphakhi R, Rerknimitr P (2021) Sinovac COVID-19 vaccine-induced cutaneous leukocytoclastic vasculitis. JAAD Case Rep 18:1\u20133. https:\/\/doi.org\/10.1016\/j.jdcr.2021.10.002","journal-title":"JAAD Case Rep"},{"key":"5718_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.abd.2021.09.003","volume":"97","author":"M Fritzen","year":"2022","unstructured":"Fritzen M, Funchal GDG, Luiz MO, Durigon GS (2022) Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. An Bras Dermatol 97:118\u2013121. https:\/\/doi.org\/10.1016\/j.abd.2021.09.003","journal-title":"An Bras Dermatol"},{"issue":"2","key":"5718_CR15","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/j.jemermed.2021.10.005","volume":"63","author":"MR Ball-Burack","year":"2022","unstructured":"Ball-Burack MR, Kosowsky JM (2022) A case of leukocytoclastic vasculitis following SARS-COV-2 vaccination. J Emerg Med 63(2):e62\u2013e65. https:\/\/doi.org\/10.1016\/j.jemermed.2021.10.005","journal-title":"J Emerg Med"},{"key":"5718_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.31486\/toj.21.0083","volume":"21","author":"MMB Mohamed","year":"2021","unstructured":"Mohamed MMB, Wickman TJ, Fogo AB, Velez JCQ (2021) De novo immunoglobulin A vasculitis following exposure to SARS-CoV-2 immunization. Ochsner J. 21:95\u2013401. https:\/\/doi.org\/10.31486\/toj.21.0083","journal-title":"Ochsner J."},{"key":"5718_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102951","volume":"20","author":"L Badier","year":"2021","unstructured":"Badier L, Toledano A, Porel T (2021) IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmun Rev 20:102951. https:\/\/doi.org\/10.1016\/j.autrev.2021.102951","journal-title":"Autoimmun Rev"},{"key":"5718_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14168","author":"ME Grossman","year":"2022","unstructured":"Grossman ME, Appel G, Little AJ, Ko CJ (2022) Post-COVID-19 vaccination IgA vasculitis in an adult. J Cutan Pathol. https:\/\/doi.org\/10.1111\/cup.14168","journal-title":"J Cutan Pathol"},{"key":"5718_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/dth.15458","volume":"21","author":"E Bostan","year":"2022","unstructured":"Bostan E, Zaid F, Akdogan N, Gokoz O (2022) Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis. J Cosmet Dermatol 21:51\u201353. https:\/\/doi.org\/10.1111\/dth.15458","journal-title":"J Cosmet Dermatol"},{"key":"5718_CR20","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/ijd.15623","volume":"60","author":"SR Cohen","year":"2021","unstructured":"Cohen SR, Prussick L, Kahn JS, Gao DX, Radfar A, Rosmarin D et al (2021) Leukocytoclastic vasculitis flare following the COVID-19 vaccine. Int J Dermatol 60:1032\u20131033. https:\/\/doi.org\/10.1111\/ijd.15623","journal-title":"Int J Dermatol"},{"key":"5718_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14551","volume":"34","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Chand S, Bhatnagar A, Dabas R, Bhat S et al (2021) Possible association between IgA vasculitis and COVID-19. Dermatol Ther 34:e14551. https:\/\/doi.org\/10.1111\/dth.14551","journal-title":"Dermatol Ther"},{"key":"5718_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/1358863X211055507","volume":"27","author":"AB Dicks","year":"2022","unstructured":"Dicks AB, Gray BH (2022) Images in vascular medicine: leukocytoclastic vasculitis after COVID-19 vaccine booster. Vasc Med 27:100\u2013101. https:\/\/doi.org\/10.1177\/1358863X211055507","journal-title":"Vasc Med"},{"key":"5718_CR23","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1111\/1346-8138.16212","volume":"49","author":"WJ Jin","year":"2022","unstructured":"Jin WJ, Ahn SW, Jang SH, Hong SM, Seol JE et al (2022) Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. J Dermatol 49:e34\u2013e35. https:\/\/doi.org\/10.1111\/1346-8138.16212","journal-title":"J Dermatol"},{"key":"5718_CR24","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10067-021-05948-5","volume":"41","author":"I Liang","year":"2022","unstructured":"Liang I, Swaminathan S, Lee AYS (2022) Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clin Rheumatol 41:1611\u20131612. https:\/\/doi.org\/10.1007\/s10067-021-05948-5","journal-title":"Clin Rheumatol"},{"key":"5718_CR25","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1111\/jdv.17547","volume":"35","author":"L Guzm\u00e1n-P\u00e9rez","year":"2021","unstructured":"Guzm\u00e1n-P\u00e9rez L, Puerta-Pe\u00f1a M, Falkenhain-L\u00f3pez D, Montero-Men\u00e1rguez J, Guti\u00e9rrez-Collar C et al (2021) Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2. J Eur Acad Dermatol Venereol 35:e741\u2013e743. https:\/\/doi.org\/10.1111\/jdv.17547","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5718_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19005","volume":"13","author":"S Shahrigharahkoshan","year":"2021","unstructured":"Shahrigharahkoshan S, Gagnon LP, Mathieu S (2021) Cutaneous leukocytoclastic vasculitis induction following ChAdOx1 nCoV-19 vaccine. Cureus 13:e19005. https:\/\/doi.org\/10.7759\/cureus.19005","journal-title":"Cureus"},{"key":"5718_CR27","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/art.41910","volume":"73","author":"A Erler","year":"2021","unstructured":"Erler A, Fiedler J, Koch A, Heldmann F, Sch\u00fctz A (2021) Leukocytoclastic vasculitis after vaccination with a SARS-CoV-2 vaccine. Arthritis Rheumatol 73:2188. https:\/\/doi.org\/10.1002\/art.41910","journal-title":"Arthritis Rheumatol"},{"key":"5718_CR28","doi-asserted-by":"publisher","first-page":"rkab050","DOI":"10.1093\/rap\/rkab050","volume":"5","author":"R Colia","year":"2021","unstructured":"Colia R, Rotondo C, Corrado A, Cantatore FP (2021) Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatol Adv Pract 5:rkab050. https:\/\/doi.org\/10.1093\/rap\/rkab050","journal-title":"Rheumatol Adv Pract"},{"issue":"49","key":"5718_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cup.14104","volume":"8","author":"V Larson","year":"2021","unstructured":"Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA et al (2021) Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID -19 vaccination. J Cutan Pathol 8(49):34\u201341. https:\/\/doi.org\/10.1111\/cup.14104","journal-title":"J Cutan Pathol"},{"key":"5718_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15279","volume":"35","author":"E Altun","year":"2022","unstructured":"Altun E, Kuzucular E (2022) Leukocytoclastic vasculitis after COVID-19 vaccination. Dermatol Ther 35:e15279. https:\/\/doi.org\/10.1111\/dth.15279","journal-title":"Dermatol Ther"},{"key":"5718_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.medcle.2021.09.019","volume":"158","author":"EM G\u00e1zquez Aguilera","year":"2022","unstructured":"G\u00e1zquez Aguilera EM, Rodr\u00edguez Garc\u00eda M, Cant\u00f3n Yebra MT (2022) Cutaneous vasculitis due to COVID-19 vaccination. Med Clin 158:493\u2013494. https:\/\/doi.org\/10.1016\/j.medcle.2021.09.019","journal-title":"Med Clin"},{"key":"5718_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102783","volume":"127","author":"G Fiorillo","year":"2022","unstructured":"Fiorillo G, Pancetti S, Cortese A, Toso F, Manara S et al (2022) Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination. J Autoimmun 127:102783. https:\/\/doi.org\/10.1016\/j.jaut.2021.102783","journal-title":"J Autoimmun"},{"key":"5718_CR33","doi-asserted-by":"publisher","first-page":"e15367","DOI":"10.1111\/dth.15367","volume":"35","author":"PR Criado","year":"2022","unstructured":"Criado PR, Giordani LP, Yoshimoto TA, Vieira IC, Landman G et al (2022) Vasculitis in the setting of COVID-19: from the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization. Dermatol Ther. 35:e15367. https:\/\/doi.org\/10.1111\/dth.15367","journal-title":"Dermatol Ther."},{"key":"5718_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/15347346221078734","volume":"21","author":"JA Uh","year":"2022","unstructured":"Uh JA, Lee SK, Kim JH, Lee JH, Kim MS et al (2022) Cutaneous small-vessel vasculitis after ChAdOx1 COVID-19 vaccination: a report of five cases. Int J Low Extrem Wounds 21:193\u2013196. https:\/\/doi.org\/10.1177\/15347346221078734","journal-title":"Int J Low Extrem Wounds"},{"key":"5718_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdcr.2021.07.002","volume":"15","author":"CT Berry","year":"2021","unstructured":"Berry CT, Eliliwi M, Gallagher S, Panaccione S, Klein WM et al (2021) Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2. vaccination. JAAD Case Rep 15:11\u201314. https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.002","journal-title":"JAAD Case Rep"},{"key":"5718_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.15570\/actaapa.2022.12","volume":"31","author":"L Dordevi\u0107Betetto","year":"2022","unstructured":"Dordevi\u0107Betetto L, Luzar B, PipanTkalec \u017d, Ponorac S (2022) Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review. Acta Dermatovenerol Alp Pannonica Adriat. 31:83\u201387. https:\/\/doi.org\/10.15570\/actaapa.2022.12","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"key":"5718_CR37","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1111\/jocd.14452","volume":"20","author":"BR Kar","year":"2021","unstructured":"Kar BR, Singh BSTP, Mohapatra L, Agrawal I (2021) Cutaneous small-vessel vasculitis following COVID-19 vaccine. J Cosmet Dermatol 20:3382\u20133383. https:\/\/doi.org\/10.1111\/jocd.14452","journal-title":"J Cosmet Dermatol"},{"key":"5718_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1346-8138.16282","volume":"49","author":"T Gambichler","year":"2022","unstructured":"Gambichler T, Abu Rached N, Scholl L, Behle B, Mansour R et al (2022) Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination. J Dermatol 49:145\u2013146. https:\/\/doi.org\/10.1111\/1346-8138.16282","journal-title":"J Dermatol"},{"key":"5718_CR39","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1177\/23247096211066283","volume":"10","author":"B Ireifej","year":"2022","unstructured":"Ireifej B, Weingarten M, Dhamrah U, Weingarten M, Hadi S (2022) Leukocytoclastic vasculitic rash following second dose of moderna COVID-19 vaccine. J Investig Med High Impact Case Rep 10:6283. https:\/\/doi.org\/10.1177\/23247096211066283","journal-title":"J Investig Med High Impact Case Rep"},{"key":"5718_CR40","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1186\/s12879-021-06655-x","volume":"21","author":"VT M\u00fccke","year":"2021","unstructured":"M\u00fccke VT, Knop V, M\u00fccke MM, Ochsendorf F, Zeuzem S (2021) First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infect Dis 21:958. https:\/\/doi.org\/10.1186\/s12879-021-06655-x","journal-title":"BMC Infect Dis"},{"key":"5718_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/jgs.17675","volume":"70","author":"P Carrillo-Garcia","year":"2022","unstructured":"Carrillo-Garcia P, S\u00e1nchez-Osorio L, G\u00f3mez-Pav\u00f3n J (2022) Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccine. J Am Geriatr Soc 70:971\u2013973. https:\/\/doi.org\/10.1111\/jgs.17675","journal-title":"J Am Geriatr Soc"},{"key":"5718_CR42","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.1016\/S2665-9913(21)00309-X","volume":"3","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, Luca G, Rizzo N, Priori R et al (2021) Cutaneous vasculitis following COVID-19 vaccination. Lancet Rheumatol 3:e743\u2013e744. https:\/\/doi.org\/10.1016\/S2665-9913(21)00309-X","journal-title":"Lancet Rheumatol"},{"key":"5718_CR43","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1016\/j.vaccine.2021.06.079","volume":"39","author":"AM Hines","year":"2021","unstructured":"Hines AM, Murphy N, Mullin C, Barillas J, Barrientos JC (2021) Henoch-Sch\u00f6nlein purpura presenting post COVID-19 vaccination. Vaccine 39:4571\u20134572. https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.079","journal-title":"Vaccine"},{"key":"5718_CR44","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/ced.14797","volume":"46","author":"V Kharkar","year":"2021","unstructured":"Kharkar V, Vishwanath T, Mahajan S, Joshi R, Gole P (2021) Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance. Clin Exp Dermatol 46:1596\u20131597. https:\/\/doi.org\/10.1111\/ced.14797","journal-title":"Clin Exp Dermatol"},{"key":"5718_CR45","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s10067-021-05993-0","volume":"41","author":"T Oskay","year":"2021","unstructured":"Oskay T, Is\u0131k M (2021) Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination. Clin Rheumatol 41:1931\u20131933. https:\/\/doi.org\/10.1007\/s10067-021-05993-0","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5718_CR46","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/vaccines9101078","volume":"9","author":"MM Sirufo","year":"2021","unstructured":"Sirufo MM, Raggiunti M, Magnanimi LM, Ginaldi L, Martinis M (2021) Henoch-Sch\u00f6nlein purpura following the first dose of COVID-19 viral vector vaccine: a case report. Vaccines (Basel) 9(10):3390. https:\/\/doi.org\/10.3390\/vaccines9101078","journal-title":"Vaccines (Basel)"},{"key":"5718_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-01025-9","author":"A Naitlho","year":"2021","unstructured":"Naitlho A, Lahlou W, Bourial A (2021) A rare case of Henoch-Sch\u00f6nlein purpura following a COVID-19 vaccine-case report. SN Compr Clin Med. https:\/\/doi.org\/10.1007\/s42399-021-01025-9","journal-title":"SN Compr Clin Med"},{"issue":"2","key":"5718_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.40375","volume":"70","author":"CH Sunderk\u00f6tter","year":"2018","unstructured":"Sunderk\u00f6tter CH, Zelger B, Chen KR, Requena L, Piette W et al (2018) Nomenclature of cutaneous vasculitis. Arthritis Rheumatol. 70(2):171\u201384. https:\/\/doi.org\/10.1002\/art.40375","journal-title":"Arthritis Rheumatol."},{"key":"5718_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijdpdd.ijdpdd_22_21","volume":"9","author":"V Mysore","year":"2022","unstructured":"Mysore V, Jindal A (2022) Histopathology of vasculitis: classification, controversies, and concepts. Indian J Dermatopathol Diagn Dermatol 9:1. https:\/\/doi.org\/10.4103\/ijdpdd.ijdpdd_22_21","journal-title":"Indian J Dermatopathol Diagn Dermatol"},{"key":"5718_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2559.2009.03443.x","volume":"56","author":"JA Carlson","year":"2010","unstructured":"Carlson JA (2010) The histological assessment of cutaneous vasculitis. Histopathology 56:3\u201323. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03443.x","journal-title":"Histopathology"},{"key":"5718_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.rdc.2014.09.006","volume":"41","author":"RG Micheletti","year":"2015","unstructured":"Micheletti RG, Werth VP (2015) Small vessel vasculitis of the skin. Rheum Dis Clin North Am 41:21. https:\/\/doi.org\/10.1016\/j.rdc.2014.09.006","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"5718_CR52","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/jcm11030739","volume":"11","author":"I Pantic","year":"2022","unstructured":"Pantic I, Jevtic D, Nordstrom CW, Madrid C, Milovanovic T et al (2022) Clinical manifestations of leukocytoclastic vasculitis, treatment, and outcome in patients with ulcerative colitis: a systematic review of the literature. J Clin Med 11(3):739. https:\/\/doi.org\/10.3390\/jcm11030739","journal-title":"J Clin Med"},{"key":"5718_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms22147538","volume":"22","author":"H Sugino","year":"2021","unstructured":"Sugino H, Sawada Y, Nakamura M (2021) IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes. Int J Mol Sci 22:14. https:\/\/doi.org\/10.3390\/ijms22147538","journal-title":"Int J Mol Sci"},{"key":"5718_CR54","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00296-024-05606-4","volume":"44","author":"D Suszek","year":"2024","unstructured":"Suszek D, Grzywa-Celi\u0144ska A, Emeryk-Maksymiuk J, Krusi\u0144ski A, Redestowicz K, Siwiec J et al (2024) IgA vasculitis after COVID-19: a case-based review. Rheumatol Int 44:1353\u20131357. https:\/\/doi.org\/10.1007\/s00296-024-05606-4","journal-title":"Rheumatol Int"},{"key":"5718_CR55","doi-asserted-by":"publisher","first-page":"1059612","DOI":"10.3389\/fmed.2022.1059612","volume":"9","author":"RG Micheletti","year":"2022","unstructured":"Micheletti RG (2022) Treatment of cutaneous vasculitis. Front Med (Lausanne) 9:1059612. https:\/\/doi.org\/10.3389\/fmed.2022.1059612","journal-title":"Front Med (Lausanne)"},{"key":"5718_CR56","doi-asserted-by":"publisher","first-page":"996288","DOI":"10.3389\/fmed.2022.996288","volume":"9","author":"CA Maronese","year":"2022","unstructured":"Maronese CA, Zelin E, Avallone G (2022) Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic. Front Med (Lausanne) 9:996288. https:\/\/doi.org\/10.3389\/fmed.2022.996288","journal-title":"Front Med (Lausanne)"},{"key":"5718_CR57","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/bjd.19338","volume":"183","author":"C Santonja","year":"2020","unstructured":"Santonja C, Heras F, N\u00fa\u00f1ez L, Requena L (2020) COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient. Br J Dermatol 183:778\u2013780. https:\/\/doi.org\/10.1111\/bjd.19338","journal-title":"Br J Dermatol"},{"key":"5718_CR58","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","volume":"68","author":"D Kanduc","year":"2020","unstructured":"Kanduc D, Shoenfeld Y (2020) Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res 68:310\u2013313. https:\/\/doi.org\/10.1007\/s12026-020-09152-6","journal-title":"Immunol Res"},{"key":"5718_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103340","volume":"22","author":"M Guo","year":"2023","unstructured":"Guo M, Liu X, Chen X, Li Q (2023) Insights into new-onset autoimmune diseases after COVID-19 vaccination. Autoimmun Rev 22:103340. https:\/\/doi.org\/10.1016\/j.autrev.2023.103340","journal-title":"Autoimmun Rev"},{"key":"5718_CR60","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/v14122655","volume":"14","author":"J \u015awierkot","year":"2022","unstructured":"\u015awierkot J, Madej M, Szmyrka M (2022) The risk of autoimmunity development following mRNA COVID-19 vaccination. Viruses 14:2655. https:\/\/doi.org\/10.3390\/v14122655","journal-title":"Viruses"},{"key":"5718_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003022","volume":"9","author":"F Ursini","year":"2023","unstructured":"Ursini F, Ruscitti P, Addimanda O (2023) Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group. RMD Open 9:e003022. https:\/\/doi.org\/10.1136\/rmdopen-2023-003022","journal-title":"RMD Open"},{"key":"5718_CR62","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/vaccines11050902","volume":"11","author":"J Castrodeza-Sanz","year":"2023","unstructured":"Castrodeza-Sanz J, Sanz-Mu\u00f1oz I, Eiros JM (2023) Adjuvants for COVID-19 vaccines. Vaccines (Basel) 11:902. https:\/\/doi.org\/10.3390\/vaccines11050902","journal-title":"Vaccines (Basel)"},{"key":"5718_CR63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/vaccines12010002","volume":"12","author":"V Brkovic","year":"2023","unstructured":"Brkovic V, Nikolic G, Baralic M, Kravljaca M, Milinkovic M et al (2023) A Study on mortality predictors in hemodialysis patients infected with COVID-19: impact of vaccination status. Vaccines (Basel) 12:2. https:\/\/doi.org\/10.3390\/vaccines12010002","journal-title":"Vaccines (Basel)"},{"key":"5718_CR64","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00296-024-05654-w","volume":"44","author":"A Alunno","year":"2024","unstructured":"Alunno A, Carubbi F, Tan AL, Sen P, Cavagna L, Joshi M et al (2024) COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study. Rheumatol Int 44:1725\u20131731. https:\/\/doi.org\/10.1007\/s00296-024-05654-w","journal-title":"Rheumatol Int"},{"key":"5718_CR65","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.jaad.2021.01.047","volume":"84","author":"LM Gresham","year":"2021","unstructured":"Gresham LM, Marzario B, Dutz J (2021) An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology. J Am Acad Dermatol 84:1652\u20131666. https:\/\/doi.org\/10.1016\/j.jaad.2021.01.047","journal-title":"J Am Acad Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05718-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05718-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05718-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:26:59Z","timestamp":1727299619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05718-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5718"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05718-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patient consent has been obtained concerning treatment and procedures, and the patient has given written consent to the publication and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}